Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

A team led by the Cancer Immunogenomics group at the Josep Carreras Leukaemia Research Institute, the Computational Biology group at the Barcelona Supercomputing Center and the Germans Trias i Pujol ...

By Dr. Priyom Bose, Ph.D. Short-term increase in thyroid cancer diagnoses observed with GLP-1RA initiation, likely driven by ...

Thyroid dysfunction associated with cancer immunotherapy commonly manifests as either ... manifestations of thyroid disorders in patients treated with ICIs. 3. Predictive markers and risk factors: ...

Thyroid cancer recurrence risk was not elevated among patients with high-normal vs low-normal exposure to TSH following thyroidectomy.

The hypothalamic–pituitary–thyroid axis plays a crucial role in the pathogenesis, diagnosis, risk stratification, effectiveness of radioiodine therapy, and treatment response evaluation in epithelial ...

Thyroid cancer is cancer of the thyroid gland in the neck. Thyroid cancer affects women more often than men. It has a good prognosis. Risk factors include a family history of this cancer, radiation ...

A biopsy is the method of definitive diagnosis. Cancer markers like CA-125, HE4, and CA-19-9 might be elevated in the blood, but are not specific for ovarian cancer. Learn More Examination of an ...

“Breast and thyroid cancer account for almost half of all cancer diagnoses in women younger than 50,” said Rebecca Siegel, lead author of the report and senior scientific director of ...

In the largest study of its kind involving a diabetic population, the use of glucagon-like peptide 1 receptor agonist (GLP-1 RA) drugs shows no significantly increased risk for thyroid cancer ...

The tissue adjacent to a tumor behaves differently than areas farther away: The tumor’s cancerous cells influence their surroundings, blocking the body’s immune defenses and creating a sort of haven ...